Literature DB >> 1703128

Preparation and characterization of monoclonal antibodies specific to synthetic peptide of carcinoembryonic antigen.

M Tsujisaki1, K Imai, N Hishikawa, S Tokuchi, Y Hinoda, H Matsukawa, S Oikawa, H Nakazato, A Yachi.   

Abstract

Monoclonal antibodies (MAbs) were prepared to a synthetic peptide (PI: 119-140 amino acids) in domain 1 of the carcino-embryonic antigen (CEA) molecule. The majority of the amino acids in peptide PI show a hydrophilic character, and similar sequences are repeated in domains I, II and III of this molecule. These MAbs appear to recognize new epitopes of CEA, since representative conventional MAbs to CEA do not show reactivity to synthetic peptide PI. The resulting MAbs were divided into 2 groups; group 1 (MAb PI-706) reacted with peptide PI, but not with purified CEA preparation, while group 2 (MAb PI-234 and PI-255) reacted with either type of antigen, in the immunoblotting assay using purified CEA and in immunostaining of colonic carcinoma tissues. Furthermore, group-1 MAb PI-706 was reactive to purified CEA after treatment with periodate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703128     DOI: 10.1002/ijc.2910470216

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

1.  Preparation and characterization of anti-anti-idiotypic monoclonal antibody ("Ab1-like Ab3") in relation to carcinoembryonic antigen.

Authors:  Masayuki Tsujisaki; Jiro Masuya; Yoshimasa Okada; Tsuneharu Jinnohara; Shigeru Sasaki; Akira Yachi; Kohzoh Imai
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

2.  Identification of a common epitope between enterovirus 71 and human MED25 proteins which may explain virus-associated neurological disease.

Authors:  Peihu Fan; Xiaojun Li; Shiyang Sun; Weiheng Su; Dong An; Feng Gao; Wei Kong; Chunlai Jiang
Journal:  Viruses       Date:  2015-03-27       Impact factor: 5.048

3.  Blockade of mIL-6R alleviated lipopolysaccharide-induced systemic inflammatory response syndrome by suppressing NF-κB-mediated Ccl2 expression and inflammasome activation.

Authors:  Ji-Min Dai; Xue-Qin Zhang; Jia-Jia Zhang; Wei-Jie Yang; Xiang-Min Yang; Huijie Bian; Zhi-Nan Chen
Journal:  MedComm (2020)       Date:  2022-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.